Lausanne

LAUSANNE, Switzerland, November 30, 2011 - Current Ceo Rudi Pauwels Becomes Executive Chairman Focusing On Scientific And Technology Strategy New CeoAppointment Strengthens Commercial Focus As BiocartisPrepares ForLaunch Of ItsFirst Product In 2013 Biocartis, a company developing and commercializing compact molecular diagnostic (MDx) systems designed to drive personalized medicine and improve the diagnosis of disease, today announced the appointment of Dr.

LAUSANNE, Switzerland, November 17, 2011 - A new study shows self-centered CEOs who "crave acclaim and applause" are more likely to keep their companies at the forefront of technological innovation.

LAUSANNE, Switzerland, November 17, 2011 - Funds Will be Used to Commercialize a Fully Automated, Compact Molecular Diagnostics System Designed to Drive the Widespread Adoption of Personalized Medicine and Other Diagnostic Applications Including the Fight Against Infectious Disease Biocartis, a company developing and commercializing compact molecular diagnostic (MDx) systems designed to drive the widespread adoption of personalized medicine and other applications including the improved diagnosis of infectious disease, announced today the completion of EUR 71 million (USD 100 million) Series C equity fund raising backed by existing investors, new investors and industrial collaborators and partners.

LAUSANNE, Switzerland, August 17, 2011 - NespressoContinuestoBuildon itsSuccessasCategory Leader Nestl Nespresso in the first half of 2011 achieved double-digit growth with more than 15% of its sales generated outside of Europe.

LAUSANNE, Switzerland, July 6, 2011 - After Monterrey in 2009 and Bali in 2010, the city of Lausanne and the Institut de Hautes Etudes en Administration Publique (IDHEAP) will be the venue for the 2011 International Congress of the IIAS (International Institute of Administrative Sciences).